Search
Now showing items 1-1 of 1
Role of adropin in arterial stiffening associated with obesity and type 2 diabetes
(University of Missouri--Columbia, 2022)
/db mesenteric arteries is abrogated by inhibition of nitric oxide (NO) synthase; and 3) stimulation of smooth muscle cells or db/db mesenteric arteries with a NO mimetic reduces stiffness. Last, in vivo treatment of db/db mice with adropin for four weeks reduced...